EUVIMEDEUVIMED entdecken
Crossref

Plasminogen Activator Inhibitor‐1 Deficiency Exacerbates Pressure Overload‐Induced Cardiac Hypertrophy in Mice

Chaoqun Huang, Shangzhi Shu iD, Xueling Yue iD, Jinshun Piao iD, Megumi Narisawa iD, Chongning Zhong iD, Longguo Zhao, Na Wang, Huayang Zhang, Yongyan Chen iD, Meiping Zhang iD, Xian Wu Cheng iD und 1 weitere

Journal of the American Heart Association · 03.11.2026 · 15 (21)

DOI: 10.1161/jaha.126.052213 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 03.11.2026. Verfasst von Chaoqun Huang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Disease The First Hospital of Jilin University Changchun China. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Cardiomegaly, Ventricular Remodeling, Serpin E2. Die Arbeit nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pathological cardiac hypertrophy is a key precursor to heart failure. PAI‐1 (plasminogen activator inhibitor‐1) is a recognized profibrotic mediator, yet its role in the heart remains paradoxical and incompletely understood.

Methods

Six‐week‐old male wild‐type (PAI‐1 +/+ ) and PAI‐1 knockout (PAI‐1 −/− ) mice underwent sham or transverse aortic constriction surgery, followed by assessment of cardiac morphology, molecular markers, and function. In H9C2 cardiomyocytes, PAI‐1 was silenced or overexpressed before angiotensin II stimulation, with or without targeted signaling inhibitors, followed by coimmunoprecipitation, Western blotting, and immunofluorescence.

Results

Pressure overload increased plasma and myocardial PAI‐1 levels. PAI‐1 deficiency exacerbated transverse aortic constriction‐induced cardiac dysfunction, hypertrophy, and fibrosis, accompanied by JAK2/STAT3 (Janus kinase 2/signal transducer and activator of transcription 3) activation and collagen overexpression, whereas cardiac‐specific overexpression attenuated these maladaptive changes. Moreover, STAT3 inhibition reversed the adverse cardiac remodeling associated with PAI‐1 deletion. In vitro, PAI‐1 knockdown potentiated angiotensin II‐induced cardiomyocyte hypertrophy, an effect that was rescued by PAI‐1 overexpression. Mechanistically, PAI‐1 associated with JAK2 and STAT3, with reduced phosphorylation of both proteins and impaired STAT3 nuclear translocation. Critically, pharmacological inhibition of STAT3 abolished the harmful effects of PAI‐1 silencing.

Conclusions

PAI‐1 acts as an endogenous cardioprotective checkpoint by negatively regulating JAK2/STAT3 signaling. These findings suggest a noncanonical cardiomyocyte‐associated function of PAI‐1 beyond its classical fibrinolytic role and identify the PAI‐1—JAK2/STAT3 axis as a potential therapeutic target for heart failure with hypertrophy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocytes, CardiacCardiomegalyVentricular RemodelingSerpin E2Plasminogen Activator Inhibitor 1AnimalsSTAT3 Transcription FactorMaleJanus Kinase 2Mice, KnockoutSignal TransductionDisease Models, AnimalMiceFibrosisMice, Inbred C57BLRatsAngiotensin IIPhosphorylation

Stichwörter der Autor:innen

JAK2STAT3cardiac hypertrophyheart failurepressure overload

Substanzen

STAT3 Transcription FactorJanus Kinase 2Stat3 protein, mouseJak2 protein, mouseSerpin E2Serpine2 protein, mousePlasminogen Activator Inhibitor 1Angiotensin IIStat3 protein, rat

Autor:innen und Institutionen

  • Department of Cardiovascular Disease The First Hospital of Jilin University Changchun China.
  • Department of Cardiology The Affiliated Hospital of Southwest Medical University Luzhou China.
  • Jilin Provincial Key Laboratory of Stress and Cardiovascular Disease Yanbian University Yanji China.
  • Department of Cardiology Nagoya University Graduate School of Medicine Nagoya Japan.
  • Department of Cardiology and Hypertension Yanbian University Hospital Yanji China.

ORCID-Profile: Shangzhi Shu, Xueling Yue, Jinshun Piao, Megumi Narisawa, Chongning Zhong, Yongyan Chen, Meiping Zhang, Xian Wu Cheng

Zitieren

APA

Huang, C., Shu, S., Yue, X., Piao, J., Narisawa, M., Zhong, C., Zhao, L., Wang, N., Zhang, H., Chen, Y., Zhang, M., Cheng, X. W., & Li, S. (2026). Plasminogen Activator Inhibitor‐1 Deficiency Exacerbates Pressure Overload‐Induced Cardiac Hypertrophy in Mice. Journal of the American Heart Association, 15(21). https://doi.org/10.1161/jaha.126.052213

Vancouver

Huang C, Shu S, Yue X, Piao J, Narisawa M, Zhong C, et al. Plasminogen Activator Inhibitor‐1 Deficiency Exacerbates Pressure Overload‐Induced Cardiac Hypertrophy in Mice. Journal of the American Heart Association. 2026;15(21). doi:10.1161/jaha.126.052213

BibTeX
@article{Huang2026,
  author = {Huang, Chaoqun and Shu, Shangzhi and Yue, Xueling and Piao, Jinshun and Narisawa, Megumi and Zhong, Chongning and Zhao, Longguo and Wang, Na and Zhang, Huayang and Chen, Yongyan and Zhang, Meiping and Cheng, Xian Wu and Li, Shuyan},
  title = {Plasminogen Activator Inhibitor‐1 Deficiency Exacerbates Pressure Overload‐Induced Cardiac Hypertrophy in Mice},
  journal = {Journal of the American Heart Association},
  year = {2026},
  volume = {15},
  number = {21},
  doi = {10.1161/jaha.126.052213}
}
Kostenlos starten →